Podcasts

Mayo Clinic orthopedic surgeon Tom Shives, M.D. and cohost Tracy McCray educate and enlighten audiences every week on the latest news as well as information about exercise, nutrition, prevention and your health. Tune in weekly as hosts and experts from Mayo Clinic and the Mayo Clinic Health System bring you health updates in an easy-to-understand, friendly approach.

Follow the Podcasts page to be notified as new episodes become available. Post a comment and share your thoughts.

PUBLIC PAGE
Mon, Jul 22 10:03am

New Drug Approved for Treating Low Libido in Women

By Margaret Shepard, Communications Specialist, @Margaret_Marie

shutterstock_121061152-1024x683

The Food and Drug Administration recently approved Vyleesi (bremelanotide) to help women with hypoactive sexual desire disorder, or low libido, which affects 8% to 10% of all women. The new drug, which will be available in September, has been referred to as “female Viagra.” However, that's a misnomer. Viagra works on blood vessels; whereas, Vyleesi acts on brain receptors.

Vyleesi is intended to treat low sexual desire that is not due to existing medical or psychiatric conditions, problems within the relationship, or the effects of a medication or other drug substance. Patients using Vyleesi will inject themselves under the skin of the abdomen or thigh at least 45 minutes before anticipated sexual activity.

On this Mayo Clinic Radio program segment, Dr. Stephanie Faubion, an internal medicine physician and the Bill and Penny George Director, Center for Women's Health at Mayo Clinic, discusses Vyleesi. She also has a warning about over-the-counter treatments for menopause symptoms.

 
Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Podcasts page.

We'll include this text in the user's invitation.